text: These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation, suggesting that << phillyrin >> is a novel [[ AMPK ]] activator with a role in the prevention and treatment of obesity.